SEARCH

SEARCH BY CITATION

References

  • 1
    Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009; 4: 8.
  • 2
    Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillen D, Alfaro M, Morales J, Hutchinson M, Katki H, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst 2010; 102: 31524.
  • 3
    Louie KS, de Sanjose S, Diaz M, Castellsague X, Herrero R, Meijer CJ, Shah K, Franceschi S, Muňoz N, Bosch FX. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer 2009; 100: 11917.
  • 4
    International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiol Biomarkers Prev 2009; 18: 10609.
  • 5
    International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006; 118: 148195.
  • 6
    International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007; 370: 160921.
  • 7
    International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 2006; 119: 110824.
  • 8
    Edelstein ZR, Madeleine MM, Hughes JP, Johnson LG, Schwartz SM, Galloway DA, Carter JJ, Koutsky LA. Age of diagnosis of squamous cell cervical carcinoma and early sexual experience. Cancer Epidemiol Biomarkers Prev 2009; 18: 10706.
  • 9
    Jeronimo J, Schiffman M. Colposcopy at a crossroads. Am J Obstet Gynecol 2006; 195: 34953.
  • 10
    Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Shin HR, Forman D. Cancer incidence in five continents, 9th edn., vols. I–IX. Lyon, France: International Agency for Research on Cancer, 2010.
  • 11
    Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954; 8: 112.
  • 12
    Plummer M. Improved estimates of floating absolute risk. Stat Med 2004; 23: 93104.
  • 13
    Doll R. An epidemiological perspective of the biology of cancer. Cancer Res 1978; 38: 357383.
  • 14
    Peto J. Dose–response relationships for asbestos-related disease: implications for hygiene standards. Part II. Mortality. Ann N Y Acad Sci 1979; 330: 195203.
  • 15
    Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 5770.
  • 16
    Peto R. Letter: cervical cancer and early sexual intercourse. Int J Epidemiol 1976; 5: 97.
  • 17
    La Vecchia C, Franceschi S, Decarli A, Fasoli M, Gentile A, Parazzini F, Regallo M. Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer 1986; 58: 93541.
  • 18
    IARC. Monographs on the evaluation of carcinogenic risks to humans, vol. 90: human papillomavirus. Lyon: IARC Press, 2007.
  • 19
    Narisawa-Saito M, Yoshimatsu Y, Ohno S, Yugawa T, Egawa N, Fujita M, Hirohashi S, Kiyono T. An in vitro multistep carcinogenesis model for human cervical cancer. Cancer Res 2008; 68: 5699705.
  • 20
    Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004; 96: 35763.
  • 21
    Pike MC, Pearce CL, Wu AH. Prevention of cancers of the breast, endometrium and ovary. Oncogene 2004; 23: 637991.
  • 22
    Allen E, Gardner WU. Cancer of the cervix of the uterus in hybrid mice following long-continued administration of estrogen. Cancer Res 1941; 1: 35965.
  • 23
    Chung SH, Franceschi S, Lambert PF. Estrogen and ERalpha: culprits in cervical cancer? Trends Endocrinol Metab 2010; 21: 50411.
  • 24
    Burger H. The menopausal transition—endocrinology. J Sex Med 2008; 5: 226673.
  • 25
    Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Muňoz N, Meijer CJ, Herrero R. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case–control study. Int J Cancer 2003; 107: 12733.
  • 26
    Moscicki AB, Winkler B, Irwin CE, Jr, Schachter J. Differences in biologic maturation, sexual behavior, and sexually transmitted disease between adolescents with and without cervical intraepithelial neoplasia. J Pediatr 1989; 115: 48793.
  • 27
    Collins S, Mazloomzadeh S, Winter H, Rollason T, Blomfield P, Young L, Woodman C. Proximity of first intercourse to menarche and the risk of human papillomavirus infection: a longitudinal study. Int J Cancer 2005; 114: 498500.
  • 28
    De Carvalho N, Teixeira J, Roteli-Martins CM, Naud P, De Borba P, Zahaf T, Sanchez N, Schuind A. Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women. Vaccine 2010; 28: 624755.
  • 29
    Dasbach EJ, Insinga RP, Elbasha EH. The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK. BJOG 2008; 115: 94756.
  • 30
    Harper DM. Preliminary HPV vaccine results for women older than 25 years. Lancet 2009; 373: 19212.